Left ventricular hypertrophy and left atrial size are associated with ischemic strokes among non-vitamin K antagonist oral anticoagulant users.
Alvin S DasElif GökçalAvia Abramovitz FouksMitchell J HornRobert William RegenhardtAnand ViswanathanAneesh B SinghalLee H SchwammSteven M GreenbergM Edip GurolPublished in: Journal of neurology (2023)
Prior cerebrovascular events, diabetes, left ventricular hypertrophy, and increased left atrial size are risk factors for developing an IS among NOAC users.
Keyphrases
- left atrial
- left ventricular
- atrial fibrillation
- mitral valve
- hypertrophic cardiomyopathy
- heart failure
- oral anticoagulants
- cardiac resynchronization therapy
- acute myocardial infarction
- type diabetes
- aortic stenosis
- cardiovascular disease
- catheter ablation
- venous thromboembolism
- glycemic control
- ischemia reperfusion injury
- coronary artery disease
- metabolic syndrome
- acute coronary syndrome
- cerebral ischemia
- adipose tissue
- skeletal muscle